Navigation Links
Aspartame passes stiff review by European Food Safety Authority
Date:12/11/2013

(Dec. 10) The widely used no-calorie sweetener, aspartame, has been deemed safe for consumption at current levels by the European Food Safety Authority (EFSA), which conducted one of the most comprehensive risk assessments ever undertaken. EFSA's opinion echoes those of numerous government agencies, including the Food and Drug Administration. EFSA also concluded that:

  • Aspartame can be used by pregnant women.
  • Aspartame does not cause cancer, harm the brain or nervous system or affect behavior or cognitive function of children or adults.

Low and no-calorie sweeteners, including aspartame, have also been reviewed by The American Heart Association, the American Diabetes Association and the American Academy of Nutrition and Dietetics, which have found them to be safe and effective.


'/>"/>

Contact: Michael Schiferl
mschiferl@webershandwick.com
312-988-2017
Weber Shandwick
Source:Eurekalert

Page: 1

Related biology news :

1. West Nile virus passes from female to eggs, but less so from larvae to adults
2. Afterburn Fuel Review Announces the Launch of its New and Informative Website
3. Cranberries have health-promoting properties, new expert review reveals
4. New report reviews science and engineering quality at national security laboratories
5. Review outlines best practice standards for coordinator-based fracture liaison services
6. Study explores effects of review setting on scientific peer review
7. Prohormonesdirect.com Offers in Depth OxyELITE Pro Reviews
8. Fat Loss Factor Review Gives Opinion of Popular Weight Loss Program
9. Detailed Flex Belt Review and Announcement of New Discount Coupon at Flex Belt Critic Site
10. 3-D Printing and Additive Manufacturing preview issue publishing Fall 2013
11. New review sets international standards for best practice in fracture liaison services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):
(Date:4/21/2017)... ... April 21, 2017 , ... The University of Connecticut, ... funding to three startups through the UConn Innovation Fund. The $1.5 million UConn ... affiliated with UConn. , The UConn Innovation Fund provides investments of up to ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... nourishing a range of emerging technology-based businesses, recently earned a $77,518 grant from ... , Founded in 2004, FITCI is Frederick’s first incubator. A non-profit corporation, ...
(Date:4/20/2017)... ... April 20, 2017 , ... USDM Life Sciences , the ... and healthcare industries, is pleased to announce Holger Braemer as Vice President ... Europe GmbH” based in Germany. , Braemer is an integral part of USDM’s ...
(Date:4/20/2017)... ... April 20, 2017 , ... Energetiq ... applications, announced today that Chief Executive Officer (CEO) Debbie Gustafson has been appointed ... the global industry association connecting the electronics manufacturing supply chain. The mission of ...
Breaking Biology Technology: